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Multimodal phantoms for clinical PET/MRI
Eve Lennie1* , Charalampos Tsoumpas2,3 and Steven Sourbron1 
Introduction
Positron emission tomography (PET) and magnetic resonance imaging (MRI) are 
both well-established clinical imaging modalities. PET images are formed by detecting 
the annihilation photons of positrons emitted by a radioactive tracer administered to 
patients [1]. These are considered functional images, as tracers are targeted to a particu-
lar physiological process, and the amount of radiation detected is proportional to the 
uptake of tracer in a region. Measures such as standardised uptake value (SUV) allow 
the radiotracer uptake of a region to be quantified. MRI detects a radiofrequency (RF) 
Abstract 
Phantoms are commonly used throughout medical imaging and medical physics for 
a multitude of applications, the designs of which vary between modalities and clinical 
or research requirements. Within positron emission tomography (PET) and nuclear 
medicine, phantoms have a well-established role in the validation of imaging protocols 
so as to reduce the administration of radioisotope to volunteers. Similarly, phantoms 
are used within magnetic resonance imaging (MRI) to perform quality assurance on 
clinical scanners, and gel-based phantoms have a longstanding use within the MRI 
research community as tissue equivalent phantoms. In recent years, combined PET/
MRI scanners for simultaneous acquisition have entered both research and clinical use. 
This review explores the designs and applications of phantom work within the field of 
simultaneous acquisition PET/MRI as published over the period of a decade. Common 
themes in the design, manufacture and materials used within phantoms are identi-
fied and the solutions they provided to research in PET/MRI are summarised. Finally, 
the challenges remaining in creating multimodal phantoms for use with simultaneous 
acquisition PET/MRI are discussed. No phantoms currently exist commercially that have 
been designed and optimised for simultaneous PET/MRI acquisition. Subsequently, 
commercially available PET and nuclear medicine phantoms are often utilised, with CT-
based attenuation maps substituted for MR-based attenuation maps due to the lack of 
MR visibility in phantom housing. Tissue equivalent and anthropomorphic phantoms 
are often developed by research groups in-house and provide customisable alterna-
tives to overcome barriers such as MR-based attenuation correction, or to address 
specific areas of study such as motion correction. Further work to characterise materi-
als and manufacture methods used in phantom design would facilitate the ability to 
reproduce phantoms across sites.
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signal emitted by protons excited by RF pulses in a strong external magnetic field [2]. 
This can produce high-resolution anatomical images with high contrast between dif-
ferent soft tissues. In recent years, combined PET/MRI scanners have been released by 
manufacturers and are entering clinical use. These scanners allow for the simultaneous 
acquisition of PET and MRI data resulting in combined images from both modalities, 
with proposed advantages in imaging for a range of clinical areas [3].
In both PET and MRI, test objects known as phantoms are used for scanner perfor-
mance testing and monitoring, verification of new image acquisition protocols and 
reconstruction methods, standardisation across equipment and other experimental 
work. PET phantoms are typically solid vessels of various sizes and geometry filled with 
different concentrations of radiotracer solution [4]. For quality assurance and perfor-
mance testing, these would typically be a single container filled with fluid to provide a 
uniform image, or larger acrylic containers with inserts of simple geometries such as 
cylinders or spheres. Anthropomorphic phantoms, with cavities which appear to match 
anatomical geometries in PET images, are used to simulate radiotracer uptake in a spe-
cific organ, often against a lower activity background.
MRI phantoms adhere to similar designs for performance testing and are often filled 
with a highly MRI-visible fluid such as nickel chloride or manganese chloride solution, 
as used in the phantom developed by the National Institute of Standards and Technology 
(NIST) and the International Society for Magnetic Resonance in Medicine (ISMRM), the 
NIST/ISMRM system phantom [5]. Anthropomorphic phantoms in MRI often use gels 
such as agar to achieve MRI relaxation properties close to human tissues [6]. In these 
existing forms, neither PET nor MRI phantoms are compatible for imaging with the 
other modality to take advantage of the simultaneous acquisition available with a com-
bined PET/MRI scanner, simply due to the difference in radiological properties required.
Valladares et al. [7] compared the quality assurance programs for PET/MRI scanners 
of 8 sites across Europe and found significant variation in approaches. The authors rec-
ommend a regime in line with available guidelines such as the National Electrical Man-
ufacturers Association’s (NEMA) report NEMA NU-2 [8] for PET and the American 
Association of Physicists in Medicine (AAPM) Report 028 for MRI [9]. This satisfacto-
rily covers performance monitoring of scanners, but still leaves both modalities tested 
individually. This doesn’t reflect clinical use of the scanners and in particular doesn’t 
allow for a complete assessment of the image reconstruction process when using MRI-
based attenuation maps with PET data. It also raises the question as to how phantoms 
have been used in the field of PET/MRI to date, and to what extent phantoms have been 
developed that are compatible for simultaneous PET/MRI.
This article examines publications between 2011 and 2021 to identify the phantoms 
used and developed by institutions working with clinical PET/MRI scanners. In order 
for a publication to be included in this review, the utility of both PET and MRI data sets 
must be demonstrated, thus indicating that the phantom chosen shows potential as a 
test object for simultaneous PET/MRI acquisitions. Mathematical and computational/
software phantoms are not considered in this review.
The main part of this review begins by summarising the materials used in phantom 
design and the challenges faced when choosing materials to create PET/MRI phantoms. 
We then categorise the phantoms identified from literature into two broad categories. 
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First, we cover geometric phantoms, those that feature simple geometries such as those 
designed for quality assurance programs, which may be commercially available or manu-
factured in-house. The second is anthropomorphic phantoms, designed to replicate spe-
cific human anatomy, physiology or tissue properties in PET/MRI for which there are 
commercially available and in-house manufactured solutions. For each category we pre-
sent phantom designs and the use cases demonstrated in recent publications, a summary 
of which can be seen in Fig. 1. We then discuss how the presented phantoms address 
key research areas posed in the field of PET/MRI, and the developments still needed 
to create widely available, reproducible phantoms suitable for simultaneous PET/MRI 
acquisitions.
Materials in phantom design
Ensuring the materials chosen for phantom development exhibit the properties required 
for both PET and MRI imaging simultaneously can be challenging as PET/CT phantoms 
focus on radiotracer distribution and electron density of materials, whilst MRI phantoms 
are optimised to the desired proton relaxation times. A list of the polymers mentioned 
in this review and their abbreviations are shown in Table  1. Polymethyl methacrylate 
(PMMA) is the preferred choice in commercially available phantoms as it is strong, 
transparent and offers a similar X-ray radiation attenuation to human tissue [1]. How-
ever, it is not MRI visible, so the attenuation properties of PMMA phantoms cannot 
be correctly derived in PET/MRI acquisitions and so alternative materials for phantom 
development have been explored.
Phantom development, including characterisation of the materials, is an active area 
of research among groups performing phantom studies in PET/MRI, with 12 phantoms 
featured in publications on phantom development between 2011 and 2021, as shown in 
Fig. 1. In-house manufactured anthropomorphic and tissue equivalent phantoms in par-
ticular are often featured in a dedicated publication to describe the phantom design and 
manufacture, or demonstrate its properties as a suitable PET/MRI phantom.
Tissue mimicking materials
A recent review on tissue mimicking materials has been published by McGarry et  al. 
[10] providing an overview of the material properties and manufacture methods across 
a range of imaging modalities. The authors outlined both the requirement for and chal-
lenges present in developing tissue mimicking material displaying the desired properties 
for multiple imaging modalities. Here, an in-depth focus on the materials used as tissue 
analogues in PET/MRI phantom development is presented, a summary of which is pro-
vided in Table 2.
Three phantoms were developed to include animal cadavers of porcine and bovine ori-
gin for bone and lung tissue. Animal cadavers can provide materials with similar struc-
ture and properties to the equivalent human tissues; however, these may be altered in 
ex vivo samples [11]. Two of these phantoms were used as part of the validation process 
for MRI-based attenuation correction [12, 13]. One study described a phantom built 
with animal femur bone and lung lobe as a feasible solution to create tissue equivalent 
phantoms for PET, CT and MRI [14]. However, consideration is required as to how com-




























Fig. 1 Research and publication categories within MRI identified in this review and the number of unique phantoms used in each category, separated by custom and commercially available 
phantom designs
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cadavers at appropriate time intervals and to accommodate for the embalming process. 
Whilst there are benefits to utilising such phantoms in work around tissue classification 
in MRI-based attenuation techniques, particularly where a range of tissue types are rep-
resented [15], there are no known and verified relaxation properties or attenuation coef-
ficients to validate against. Applications are also limited by a lack of anthropomorphism 
and the limitation of introducing a meaningful and realistic radiotracer distribution to a 
cadaver.
Soft tissue
Three approaches to modelling brain tissue are encountered in this review. The Hoff-
man phantom [16] (Data Spectrum Inc.) and Iida phantom [17] both form models of 
the human head using polymers for white matter and an open compartment filled with 
radiotracer solution for grey matter. This provides an ideal radiotracer distribution, but 
the polymer structure is invisible to MRI. Saline soaked cotton as used by Okazawa et al. 
offers limited use as a brain tissue surrogate given that in the form presented no radi-
otracer is administered [18]. Agarose gel used by Harries et al. benefits from displaying 
closer MRI signal properties to soft tissue than water or saline [19]; however, establish-
ing a detailed grey and white matter structure could be challenging in terms of structural 
Table 1 Abbreviations and corresponding full names of polymers used in the manufacture of 











Table 2 Materials used in anthropomorphic phantoms categorised by the tissues they have been 
used to represent
Tissue type Materials used
Brain Agarose gel, PE, saline soaked cotton, water
Bone Gypsum plaster, dipotassium phosphate, cadaver, petroleum jelly
Soft tissue Agarose gel, methyl-cellulose gel, gelatin, gel (unspecified), saline, water
Adipose Peanut oil, silicone
Tumour/lesion Wax, agarose gel, gel (unspecified), gelatin, plastic or glass spheres
Heart Silicone, gel (unspecified), water
Lung Rubber balloon, cadaver, silicone
Other tissue Rubber balloon, hosepipe, silicone, agarose gel
Other materials PMMA, VeroClear, Agilus 30 clear, PU, PU/PVA mix
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integrity, level of detail achievable and how a heterogeneous radiotracer distribution 
could be established or even reproduced.
Agarose, gelatin and methyl-cellulose gels are used more widely as soft tissue surro-
gates in several phantoms identified for this review [13, 14, 20–23]. The ability to cus-
tomise the MRI relaxation properties of gels with relative ease at manufacture by varying 
the concentration of gelling and contrast agents, demonstrated extensively by Gillmann 
et al. [21], allows for flexibility in the number of tissue types represented. Gels can be 
used to fill cavities or moulded to hold structure without a casing, both of which pro-
vided a reproducible geometry. Moulded structures such as tumours or lesions may then 
be placed inside a larger gel tissue surrogate [23]. In phantoms simulating cardiac and 
respiratory motion [20, 24–26], gels offer an alternative to water whilst maintaining the 
flexibility to allow movement to occur. Additionally, gels are easily manufactured in-
house without the need for specialist equipment.
However, if using short half-life radiotracers such as [ 18F]FDG, gel tissue surrogates 
must be remade each day they are required, so manufacture and setting time must be 
accounted for to ensure sufficient radiation is detectable at time of scanning. Alterna-
tively, a long half-life radionuclide could be suspended within the gel, but this would 
require careful consideration of the safe long-term storage and disposal of the radio-
active gel. Furthermore, each manufacture session is subject to a level uncertainty. 
McIlvain et  al. [27] have encouraged sites to understand the impact the variations in 
manufacture may have on the material properties. Using gels inside intricate casings 
may introduce air bubbles during manufacture, and be difficult to clean for reuse. Finally, 
all of the phantoms identified in this review use homogeneous radiotracer distribution 
throughout each gel tissue surrogate; however, this does not represent every clinical sce-
nario as highlighted by Valladares et al. [28], who presented proposed solutions for het-
erogeneous tissue equivalent materials for medical imaging phantoms.
Bone
Bone material analogues are challenging to create for PET/MRI applications as the cho-
sen material should exhibit a cortical bone, or average bone, electron density for realistic 
PET attenuation, whilst maintaining very short T1 and T2 relaxation times.
Phantoms with bone surrogates were most commonly created in house using gypsum 
plaster [19, 21, 29] doped with iodine CT contrast agents and either gadolinium MRI 
contrast agents or copper sulphate to modify the linear attenuation coefficient and relax-
ation times respectively. Chandramohan et al. [29] assessed the radiological properties 
of several samples of gypsum plaster mixed with varying concentrations of each dop-
ing agent for comparison with human bone. They found that plaster doped with cop-
per sulphate provided the combined radiological properties suitable to mimic cortical 
bone; however, the relaxation properties of the material were unstable over time and 
were affected by the introduction of microbubbles into the plaster during manufacture, 
warranting further investigation. Harries et  al. [19] casted a skull from iodine doped 
plaster, which is classified as bone in five out of six MRI-based attenuation maps, but 
results in an underestimation of PET activity within the phantom of on average 5%, to 
a maximum of 11%. Gillmann et al. [21] took additional steps to create bone structures 
that also include a bone marrow surrogate of petroleum jelly mixed with dipotassium 
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hydroxide, allowing for lesions to be place inside. As the use of PET/MRI in areas of 
the body with larger bone structures increases, the differentiation between cortical bone 
and other features such as bone marrow may become more relevant in phantom experi-
ments. Dipotassium phosphate was used as a bone equivalent material in the Iida phan-
tom [17]; however, as a liquid solution it is highly visible in MRI images and so is not 
classified as bone in MRI-based attenuation maps [30].
Overall, gypsum plaster has presented a promising solution to replicating the mate-
rial properties of cortical bone in PET/MRI phantoms and is a widely available crafting 
material. However, further work is required to assess the effects of different manufactur-
ing methods and the long term stability of the material properties of doped plaster, as 
has previously been performed for agarose gels in MRI phantom work [27].
Adipose tissue
Fats are largely ignored across the phantoms produced, with only individual use of sili-
cone [19] and peanut oil [21]. Of these materials, peanut oil provided MRI relaxation 
properties close to those of adipose tissue, whilst silicone exhibits a much shorter T2* 
[19]. Phantoms designed to represent anatomy such as the breast would benefit from 
further investigation into use of materials with radiological properties similar to adipose 
tissue.
Polymers and 3D printing
Casings for organs and the overall phantom were manufactured using a variety of poly-
mers. Most commonly, PMMA and PU were used, but 3D printable polymers were also 
used for individual organs. Of the phantoms featured in this review, the Iida phantom 
[17] provided attenuation properties for the 3D printed polymer and Talalwa et al. [31] 
demonstrated the dielectric properties of their proposed porous MRI-visible 3D printed 
polymer made of a PU/PVA mix. Gillman et al. [21] reported the CT Hounsfield units 
and MRI relaxation times for VeroClear (Stratasys) but this is not referenced to any tis-
sue value, suggesting it was not selected to exhibit tissue equivalent properties.
In their systematic review to identify trends in the use of 3D printing in the develop-
ment of medical imaging phantoms, Fillipou and Tsoumpas [32] found that radiological 
properties are not commonly tested by manufacturers for 3D printing. However, Rausch 
et al. [33] have recently created a phantom using 3D printed polymer RGD252 (Strata-
sys), previously demonstrated as MRI visible [34], that is visible in both modalities for 
simultaneous PET/MRI acquisitions.
NIST have released two publications [35, 36] demonstrating CT and MRI properties 
for a range of commercially available 3D printable polymers for comparison with human 
tissue. Although several challenges exist to utilising 3D printed phantoms in multimodal 
imaging [32], future work would benefit from further consideration of the MRI relaxa-
tion and PET attenuation properties when choosing polymers from which to 3D print 
PET/MRI phantoms. In particular, this would encourage the correct classification of 
structures for MRI-based attenuation correction. Silicone and rubber balloons used to 
represent the heart [20, 24], lung [25, 26] or bladder [21] also lack MRI visibility. Whilst 
this is less of an issue for lung tissue as this is typically classified as air, care must be 
taken to ensure this does not lead to an under estimation of PET activity.
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Summary of materials in PET/MRI phantom design
Gel-based phantoms with radiotracer introduced prior to setting provide the option of 
creating phantoms with soft tissue equivalent MRI relaxation times with a uniform radi-
otracer distribution; however, radiotracer solutions of water or saline are also commonly 
used and may be doped with gadolinum-based contrast agent. Gypsum plaster has been 
the most utilised option for bone analogue materials; however, further work is required 
to establish the stability of the phantoms produced and reproducibility of manufacture 
methods. Few options have been explored in mimicking adipose tissues. Advances in 3D 
printing and the range of polymers available may offer solutions in the future in creat-
ing phantoms for simultaneous PET/MRI, particularly in light of the work performed 
in assessing the radiological properties of materials available. However, these materials 
generally lack the large scale manufacture and shelf life capable of creating reproducible 
phantoms able to be distributed across multiple sites. Subsequently, established poly-
mers in phantom design such as PMMA continue to be used widely for building PET/
MRI phantoms despite their lack of signal in MRI.
Geometric and homogeneous phantoms
Geometric phantoms are those which feature simple geometric inserts and cannot be 
considered anthropomorphic. Homogeneous phantoms are phantoms for which there 
are no inserts, providing a uniform fluid distribution within the phantom body. Twenty-
five geometric or homogeneous phantoms were identified in this review, a breakdown of 
which is shown in Fig. 2. Although this is only slightly more than half of the phantoms 
encountered, they appear in 59 of the 92 publications reviewed. Thirteen of these take 
the form of geometric phantoms, often used in quality assurance measurements. The 9 
homogeneous phantoms take the form of a cylindrical container, bottle or canister filled 
with a single fluid, and are considered to be commercially available.
Of the geometric phantoms, 9 are custom designed and included in 14 publications. 31 
publications use 5 commercially available geometric phantoms, the most common being 
the International Electrotechnical Commission (IEC) NEMA Body Phantom featured in 
Fig. 2 Physical PET/MRI phantoms categorised by design features. Material samples consist of small amounts 
of material for characterisation. The fruit category refers to the use of modified fruits as PET/MRI test objects, 
although these are not discussed in detail
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19 publications. The predominant use cases for these phantoms within PET/MRI litera-
ture are measuring image quality and scanner performance, verifying MRI-based attenu-
ation correction and image reconstruction methods and generating attenuation maps for 
radio-frequency coils or other hardware.
Homogeneous phantoms
Homogeneous phantoms act as a test object filled with a single, homogeneous fluid, 
an example of an MRI acquisition for which is shown in Fig. 3. These are simple to use 
and give indication of performance through assessment of image uniformity and image 
noise. They are easily accessible, given that they can be fashioned from any water-tight, 
MRI safe container. The variety of containers available allows researchers to tailor the 
size of the phantom appropriately.
MRI signal properties can be improved by using nickel sulphate [37], sodium chloride 
[38] or introducing a gadolinium-based contrast agent [39] alongside the radioactive 
tracer to reduce artifact in large phantoms. This allows researchers to create solutions 
that can be imaged with both PET and MRI; however, containers are not MRI visible 
and so cannot be included in MRI-based attenuation maps. This can be mitigated by 
using containers with thin walls to minimise PET attenuation by the container and allow 
for attenuation maps to be approximated to the fluid volume. No two groups of authors 
used the same uniform phantom, and phantom volumes range from 160  mL to 29  L. 
This reflects the differences in studies presented, but also suggests a lack of a standard-
ised approach to assessing uniformity in PET/MRI.
Fig. 3 Cross section of a uniform phantom acquired in MRI (GE Signa PET/MRI scanner)
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Commercially available geometric phantoms
All commercially available geometric phantoms featured in this review are phantoms 
initially designed for PET or Nuclear Medicine use and licensed by Data Spectrum 
Corporation:
• IEC (NEMA) Body Phantom
• Esser (ACR) PET Phantom
• Jaszczak Phantom
• NEMA 94 PET Phantom
• Mini Deluxe Phantom
They are widely available and many sites with existing Nuclear Medicine and PET facili-
ties are likely to already possess a subset of these phantoms in order to adhere to qual-
ity assurance guidelines [8]. In particular, the IEC (NEMA) Body Phantom continues 
to be recommended for PET and PET/MRI acceptance testing and quality assurance 
under the NEMA NU-2 (2018) standard [7, 8]. It consists of a large, elliptical PMMA 
container with a central cylinder filled with polystyrene, around which hollow spheres 
are suspended from one end of the phantom. The standardised geometry, manufacture 
and protocols used ensure comparable measurements between sites and promote repro-
ducibility across different scanners. This is reflected in literature through publications 
where the IEC Body Phantom was used to evaluate PET/MRI scanner performance [40–
42] and compared performance and protocols to PET/CT [43–46] prior to introducing 
patients studies. Krokos et al. [41] illustrated the crucial example of ensuring standardi-
sation between several PET/MRI scanners for use in multicentre dementia trials.
A significant drawback of these phantoms is the inability to create accurate MRI-based 
attenuation maps due to the widespread use of PMMA for the phantom body and its 
lack of visibility in MRI. Ziegler et al. [47] compare results generated from the NEMA 
NU-2 Protocol for a Siemens Biograph mMR using images reconstructed with both an 
MRI-derived attenuation map and a CT-derived attenuation map. They found that using 
an MRI-derived attenuation map decreased contrast recovery in radioactive spheres, 
increased contrast recovery in non-radioactive spheres and increased background var-
iability, indicating a degradation in both image quality and PET quantification due to 
insufficient correction for attenuation. Their recommended solution was to acquire a CT 
scan of the phantom separately in order to generate a suitable attenuation map that can 
be registered to the MRI or PET images to perform image reconstruction of the phan-
tom offline. Further comparisons [48] extended this to include the MRI-based attenua-
tion correction methods employed in the Philips Ingenuity TOF and GE Signa PET/MRI 
scanners for phantoms, as well as assessment of clinical MRI-based attenuation correc-
tion in phantom studies. Replacement of the MRI-based attenuation map with a regis-
tered CT-based map appears to be the preferred solution in publications included in this 
review where geometric phantoms are used. As such, vendors provide a predefined PET 
attenuation map in the scanner reconstruction software for the IEC Body Phantom for 
PET performance testing under the NEMA protocol; however, this doesn’t extend to all 
commercially available phantoms.
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Addressing MRI visibility of commercially available phantoms
In an earlier publication, Ziegler et al. [49] assessed a variety of fluid fillings to improve 
MRI visibility and attenuation map generation for the IEC Body Phantom. By varying 
the fluid filling for the phantom, they were able to significantly improve homogeneity in 
the MRI images and reduce bias in PET data resulting from inconsistencies in the MRI-
based attenuation map. The key finding was that a pure water radiotracer solution as 
recommended in the NEMA NU-2 protocol was the least suitable of the fluids assessed, 
with triethylene glycol providing the greatest homogeneity. However, none of the flu-
ids presented appear to provide a robust solution for routine use due to risk of toxicity, 
additional cleaning requirements and costs. Use of any alternative fluids also does not 
address a lack of phantom housing visibility in MRI.
Currently, no geometric phantoms for the quality assurance of PET/MRI systems exist 
on the market that are both PET and MRI visible. Whilst many performance issues will 
be detected by separate testing of MRI and PET components of the scanner, enabling 
quality assurance phantoms to undergo simultaneous imaging and use the same attenu-
ation correction and image reconstruction methods as would be used clinically is highly 
desirable. This would act to both confirm the performance of these systems and to allow 
phantom testing to form part of wider imaging protocol validation projects. Addition-
ally, there is little standardisation in MRI quality assurance programs [7], increasing the 
likelihood of cross-site variation in PET quantification given clinical reliance on MRI-
based corrections. It is clear that more work is to be done in this area, either through 
alteration of MRI sequences used to generate phantom attenuation maps, or through the 
development of phantoms from materials exhibiting properties that allow for their visu-
alisation in MRI acquisitions.
Custom designed geometric phantoms
The custom designs of geometric phantoms featured in this review are all borne from 
a requirement to test features for which no commercial option existed, often extending 
beyond performance testing of clinical PET/MRI scanners.
Rectangular whole body phantom
Braun et  al. [50] assessed the feasibility and performance of continuous table motion 
acquisitions in PET/MRI by developing a large polypropylene (PP) rectangular phantom 
to approximate the dimensions of the human body, which was separated into cubic com-
partments. Each compartment had holes of varying size drilled into the sides to visu-
ally assess image quality and quantitatively assess resolution in both PET and MRI. The 
phantom was filled with a radiotracer solution. Whilst this phantom addressed the ques-
tion it was designed for and was able to assess both PET and MRI performance [50, 51], 
it still suffered the same set-backs as commercially available phantoms and requires an 
external CT-based attenuation map to be used during PET reconstruction.
Phantoms to study motion correction
In their assessment of motion correction methods, cylindrical acrylic phantoms filled 
with water and containing inserts featuring 22 Na point sources were used by two groups 
[52, 53]. Given that a CT-based attenuation map was required for the reconstruction of 
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PET data in order to account for the trolleys and bases used in these studies, the ability 
to generate an MRI-based attenuation map may have not been a design priority. How-
ever, in both cases motion correction was informed by MRI data and so MRI visibility of 
the phantom was crucial. Previously, a phantom made of PVA cryogel with radiotracer 
introduced during manufacture was demonstrated as a PET and MRI visible phantom 
able to undergo non-rigid movement [54].
MRI visible polymers in phantom design
Rausch et al. [33] demonstrated the first PET/MRI phantom in-house-made with MRI 
visible housing. The cylindrical phantom had rod features on the bottom lid, whilst keep-
ing the top section of the phantom homogenous. The phantom was filled with an aque-
ous solution of [ 18F]FDG, sodium chloride and a gadolinium-based MRI contrast agent. 
They compared PET reconstructions of the phantom performed using no attenuation 
map, attenuation maps generated from the Siemens Biograph mMR DIXON sequences, 
an optimised phantom-specific MRI-based attenuation map and PET/CT images. Their 
work demonstrated that polymers are available for phantom construction that can be 
imaged by simultaneous PET/MRI, although the MRI-based attenuation map overesti-
mated the phantom extent. Further work should be done to verify approaches for opti-
mising MRI-based attenuation maps for phantoms using MRI visible polymers across 
different scanner models.
Geometric phantoms for brain PET/MRI
Grant et al. [55] first demonstrated a 3D printed geometric image quality phantom for 
performance testing the BrainPET (Siemens Healthcare) [56] MRI insert, for which the 
full characterisation is presented by Bieniosek et al. [57]. It was a cylindrical phantom 
with one empty quadrant containing plastic rods and three quadrants of solid polymer 
with cylindrical holes in a range of diameters. The empty spaces were then filled with a 
radiotracer solution. The group used the phantom for two further publications [58, 59]. 
The use of 3D printing in phantom development is increasing due to the widespread 
availability of 3D printers and low manufacturing costs [32], but the field lacks consist-
ent assessment of the reproducibility in 3D printed phantoms. The publication of the 
phantoms design, manufacture and characteristics [57] facilitates the ability for other 
groups with 3D printing capabilities to produce and use this phantom in further work. 
Additionally, they validated the manufacture method through replication of a commer-
cially available phantom and compared PET/CT acquisitions of the commercial and 
in-house printed phantoms [57], confirming its suitability for phantom manufacture. 
However, the phantom design does not address MRI visibility of the phantom housing 
and attenuation correction adequately.
Size appears to have been the driving factor for custom phantoms in brain PET. A 
cylindrical PMMA phantom with hollow rods and a polytetrafluoroethylene (PTFE) 
insert was utilised to validate the use of an orbiting transmission point source for 
attenuation correction of PET data compared to that of an MRI-based attenuation map 
[60]. The authors addressed the challenges in generating accurate MRI-based attenua-
tion maps through implementation of a transmission source mechanism in generating 
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attenuation maps for brain PET/MRI [60]. However, this was then used to replace the 
MRI-based attenuation map entirely with one derived from the transmission source 
measurements, requiring the use of a specialised MRI coil that is applicable to head 
imaging only.
Geometric phantoms in radiosurgery planning
Lim et  al. [61] used two acrylic phantom designs in their study on the feasibility of 
using [ 11C]methionine PET in Gamma-Knife radiosurgery planning. This required 
phantoms that are suitable in validating multiple imaging modalities as they are intro-
duced into the radiotherapy planning framework. These phantoms were imaged with 
CT, MRI and PET to assess geometric accuracy, image registration and quantitative 
PET within the Gamma-Knife radiosurgery planning system.
Summary of geometric phantom designs
Each of these phantoms is used at one site and designed to address specific research 
questions, with only one fully presented and characterised to promote its use by 
other institutions. Characterisation of materials and methods presents a barrier to 
widespread adoption of in-house manufacture methods such as 3D printing [32], as 
each group must then perform these measurements. The design and verification of a 
phantom require a significant time commitment, and so distribution of this informa-
tion is valuable to the imaging community to accelerate phantom development. Most 
recently, an MRI visible polymer has been demonstrated as suitable for PET/MRI use 
[33], providing a potential solution to MRI-based attenuation correction issues in 
phantom studies.
Fig. 4 Anthropomorphic PET/MRI phantoms categorised by the area of human anatomy they represent
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Anthropomorphic phantoms
A total of 20 anthropomorphic and tissue equivalent phantoms were identified in this 
review, of which 16 are custom-designed or in-house-manufactured. These phantoms 
cover 5 areas of human anatomy, as displayed in Fig. 4, with a final category describing 
phantoms that contain materials equivalent to specific human tissues but do not repre-
sent any specific anatomy.
Head and brain phantoms are the most published category of anatomical phantoms 
at 16 publications. This reflects the commonly desired clinical PET/MRI application of 
neurology and the subsequent areas of research addressing attenuation correction in 
brain imaging [62]. Correcting for bulk and physiological motion are also an important 
area of interest, the mechanisms of which are beyond the scope of this review, but are 
presented by Polycarpou et al. in their recent review [63]. Physiological motion in par-
ticular requires the use of phantoms able to replicate the anatomical geometries and 
motion required. Again, this is reflected in the phantoms designed and their publica-
tions with 7 torso and cardiac phantoms used across 14 publications.
Commercially available anthropomorphic phantoms
As with geometric phantoms, the commercially available options utilised for PET/MRI 
are phantoms originally designed for Nuclear Medicine and PET. These phantoms are 
well established within the field due to the necessity of administering a radioactive tracer 
for PET and γ-camera imaging limiting the recruitment of volunteers for investigative 
work. By comparison, MRI phantoms often focus on quantitative performance through 
simple geometries [64], although some anthropomorphic MRI phantoms are commer-
cially available and tissue equivalent materials are in use throughout the MRI commu-
nity [6].
Hoffman phantom
The Hoffman brain phantom [16] (Data Spectrum Corporation) is one of the most pop-
ular anthropomorphic phantom featured in 7 publications identified by this review. It 
is a PMMA cylinder containing 19 composite polycarbonate plate inserts which, when 
filled with fluid, simulate normal [ 18F]FDG radiotracer distribution in the brain and a 
realistic MRI proton density distribution. Optional inserts are also available to simulate 
defects. The Hoffman phantom has been used to assess the performance of PET inserts 
in clinical MRI scanners [65–67], evaluate motion correction methods [68, 69], the dem-
onstrate of PET image reconstruction methods [70] and MRI-based attenuation correc-
tion [71] methods. This is the only commercially available phantom identified within this 
review that is also advertised for MRI use, although the polycarbonate plates are not 
visible in MRI. The design lacks a skull component for a realistic attenuation profile, it 
does not replicate brain tissue relaxation properties in MRI, and the cylindrical design 
does not conform to human head geometry, which are major limitations for its use as a 
human head surrogate in PET/MRI.
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Torso phantoms
Two commercially available phantoms of the Thorax were used: the elliptical Lung-Spine 
[72] and Anthropomorphic Torso Phantom [73]. Both phantoms are licensed by Data 
Spectrum Corporation and are constructed from PMMA with polystyrene-filled lung 
inserts, solid PTFE spine insert and an optional PMMA cardiac insert modelled on the 
left ventricle and myocardium. The Anthropomorphic Torso phantom also features a 
liver insert. The phantom body, cardiac and liver inserts are then filled with radiotracer 
solution. A PU cardiac insert (Radiology Support Services) representing two cardiac 
chambers and the myocardium was used independently in one study [74].
Commercially available anthropomorphic phantom summary
All of the commercially available anthropomorphic phantoms are constructed from 
PMMA or PU, and so any solid material is not MRI visible. Despite the concerns raised 
around MRI-based attenuation correction in geometric phantoms, many studies use 
MRI-based attenuation maps to reconstruct PET data for these anthropomorphic phan-
toms, including two studies actively using these phantoms to assess the impact of using 
MRI-based attenuation correction [71, 73]. This may be because the differences between 
MRI-based and CT-based attenuation correction in PET quantification still need to be 
quantified prior to clinical use, or because MRI-based attenuation methods based on tis-
sue segmentation from anatomical maps [75] are more easily applied to anthropomor-
phic phantoms than non-anatomical shapes.
The current commercially available phantoms are only able to assess brain and cardiac 
protocols. This excludes some key applications of interest in clinical PET/MRI, such as 
[ 68Ga]-PSMA imaging in prostate cancer patients [76]. Crucially, no commercially avail-
able anthropomorphic phantoms are able to accurately represent human tissue in both 
PET and MRI.
Custom anthropomorphic phantoms
Whilst an accurate representation of anatomical geometry is a key aspect of design 
across all anthropomorphic phantoms, many in-house manufactured phantoms identi-
fied in this review take additional steps to achieve both PET and MRI tissue equivalence, 
or mimic additional physiological properties.
Head and brain phantoms
Three human head phantoms were developed between 2011 and 2021. The first of these 
was the Iida Brain phantom [17], initially developed for use in PET and single-photon 
emission computed tomography (SPECT) imaging, it is designed to represent a realistic 
human head contour and include a cavity around the brain material filled with dipo-
tassium phosphate to simulate the skull. Both of these features address some of the 
limitations presented by the Hoffman phantom in brain imaging. The phantom was 
manufactured through 3D printing, for which Iida et al. [17] demonstrated a high degree 
of reproducibility. The Iida phantom has been assessed for PET/MRI use, with Johans-
son et al. [77] providing a description of potential applications, highlighting the issues 
around a lack of white matter radiotracer distribution and difficulties with MRI-based 
attenuation correction when scanned with the Phillips Ingenuity PET/MRI scanner, but 
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ultimately concluding it to be a useful test object. The Turku PET Centre group later 
used the phantom in three additional PET/MRI publications [30, 71, 78] including an 
international multi-centre study.
Harries et al. [19] presented their solution for a human head phantom with a focus on 
mimicking both MRI and PET tissue properties. The authors detailed the relevant prop-
erties of their chosen materials as well as the limitations in the design and manufacture 
of this phantom. In particular, the design did not mimic the structures of grey and white 
matter in the brain, so whilst the feasibility of manufacturing such a phantom and its 
compatibility with MRI-based attenuation methods was demonstrated, applications may 
be limited due to the reduced detail in brain structure compared to the Iida and Hoff-
man brain phantoms. Additionally, this phantom necessitates in-house manufacture due 
to the use of short shelf-life materials such as agar. As a result, a centre reproducing this 
phantom should still perform validation measurements to ensure the desired material 
properties and geometries have been achieved. Finally, Okazawa et al. [18] used a human 
skull filled with saline-soaked cotton and radiotracer filled rubber tubes to represent 
arteries. This phantom was specifically designed to address the authors research ques-
tion regarding the reliability of quantitative [ 15 O] imaging in the carotid arteries using 
PET/MRI.
Torso phantoms
Larger phantoms representing the pelvis [21] [38] and torso [22] have also been designed 
and used within PET/MRI. These phantoms feature multiple organs with differing tissue 
properties and radiotracer uptake, and so 3D printing was utilised to enable the indi-
vidual design of each component. Currently, the printable materials commonly available 
to sites without an extensive manufacturing department are limited in the tissue-equiv-
alent properties they can display [10, 32]. As a result, groups developing these phan-
toms often opted to either 3D print an outer shell of the organ of interest which may be 
filled with an appropriate tissue-equivalent material, or use a 3D printed mould to cast a 
model using a gel or wax.
The ADAM PETer pelvis phantom [21] was designed for applications regarding the 
use of multimodal imaging in radiotherapy. It was based on the ADAM-pelvis phantom 
[79], by further developing the model to be compatible with PET imaging in addition 
to CT and MRI with the aim to utilise the phantom in the optimisation of PET/MRI 
guided radiotherapy for prostate cancer patients [21]. The ADAM PETer also intro-
duced 3D printing into the phantoms manufacture to improve the modular design. The 
phantom featured a large number of materials to simulate various tissues, which were 
extensively described along with the phantoms lengthy assembly process. However, the 
authors reported that due to a modular design, switching out of organs of interest was 
less laborious once the phantom was constructed and so allowed customisation of the 
phantom for several clinical scenarios [21]. Further work validating the reproducibility 
of 3D printing organ modules for this phantom would facilitate its use external to the 
home institution.
Another pelvis phantom [38] consisting of a PMMA container filled with a radiotracer 
solution has also been tested. It was noted that the phantom is described in other works 
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excluded by the review criteria [80, 81] as featuring multiple organ inserts; however, 
these features were not highlighted in any of the PET/MRI work.
The Wilhelm Anthropomorphic Torso Phantom [22] has been developed by the Euro-
pean Institute of Molecular Imaging as a phantom for PET, CT and MRI capable of rep-
licating cardiac and lung motion. Bolwin et al. [22] described the design, manufacture 
and characterisation extensively; however, this phantom has been used by the institute 
in several works addressing motion correction in PET/MRI since 2011 [82–85]. Wilhelm 
features inflatable silicone lung inserts and a silicone cardiac insert. Both sets of inserts 
are piston driven to induce motion. A double silicone membrane is used for the cardiac 
insert to create an outer layer that can be filled to represent the myocardium, a sche-
matic for which is shown in Fig. 5. Lung inflation is controlled from the base of the lungs 
by a rubber membrane to simulate the diaphragm. A liver compartment is also included. 
The phantom could be customised by the choice of fluid filling for each compartment 
and additional wax spheres mounted within the phantom as lesions. Models of the heart 
and lungs were 3D printed to create moulds on which to shape the silicone. No skeletal 
structure was featured in the phantoms’ design which may limit its application in other 
areas of interest such as MRI-based attenuation correction.
Motion correction is an on-going area of research with different methods appropriate 
to assess different types of motion [63]. As such, the Wilhelm phantom occupies a niche 
the needs of which have not been met by commercial vendors. However, this phantom is 
highly complex, having been developed over many years [22], with a multitude of mate-
rials and manufacture methods required for its construction.
Cardiac and lung phantoms
Inflatable double-membrane cardiac phantoms of a reduced complexity have also been 
demonstrated as suitable for motion correction applications in PET/MRI [20, 24]. These 
phantoms focussed exclusively on cardiac motion, placing one balloon inside another, 
filling the interspace with a mix of radiotracer, gadolinium-based contrast agents and 
gelling agent to represent the myocardium. This was then suspended within a second 
radiotracer gel mix to simulate a soft tissue background. Similarly, a single membrane 
Fig. 5 A schematic demonstrating the general design concepts of phantoms to simulate cardiac motion, as 
used by [20, 22, 24]
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balloon has been used to simulate respiratory motion [25, 26]. The materials in these 
phantoms are more widely accessible to sites without the large time, cost and facilities to 
create a phantom as complex as the Wilhelm phantom. However, these phantoms were 
not described as extensively and are less representative of the clinical scenario both ana-
tomically and in terms of physiological motion.
In myocardial perfusion, O’Doherty et  al. [86] used a different phantom, initially 
designed and described as an MRI phantom [87], to demonstrate the feasibility of first 
pass myocardial perfusion imaging in PET/MRI. The phantom featured four chambers 
simulating the atria and ventricles of the heart, with two cylindrical compartments each 
side representing the myocardium. Tubes representing veins and arteries have been 
arranged such that the flow of fluid through the phantom simulates entry to the heart 
from the vena cava. Water is delivered to the phantom from an external pump and con-
trol unit. The phantom was demonstrated as suitable for PET/MRI; however, the lack 
of tissue equivalent materials and true anthropomorphism may impact how applicable 
any results are to clinical imaging. Matusiak [88] presented a multimodal heart phantom 
(MHP) constructed of PMMA featuring two chambers to simulate left and right ventri-
cles and a surrounding space to simulate the myocardium. The imaging compatibility of 
the phantom across SPECT, PET, CT and MRI was demonstrated through visual assess-
ment and image registration between the imaging modalities [88], but no quantitative 
data were presented.
Breast phantom
A modular breast phantom was presented by Aklan et al. [89]. Breast imaging in MRI 
uses specialised RF coils for which anthropomorphic phantoms are not typically avail-
able. The modular breast phantom consisted of two PMMA domes with optional MRI 
and PET/MRI inserts. The PET/MRI insert features four sizes of glass sphere to be filled 
with radiotracer solution assembled onto a cross structure that is MRI visible [89]. This 
phantom was more of a hybrid between the anthropomorphic and geometric phantoms, 
as the insert features are more representative of those expected in a quality assurance 
phantom and when filled with water does not replicate the tissue composition of the 
breast. However, the design has been well described and offers a solution to performance 
testing and validation of equipment and protocols for breast imaging in PET/MRI, for 
which the only alternative demonstrated has been uniform bottle phantoms [39].
Summary of anthropomorphic phantom designs
The in-house manufacture of anthropomorphic phantom featured in this review have 
demonstrated numerous benefits. One is the relatively low cost of producing phantoms 
where manufacturing techniques such as 3D printing [32] and casting from moulds are 
used. The other is that increasingly complex phantoms can be developed to address spe-
cific needs within the field of medical imaging, as with the Wilhelm phantom [22] and 
ADAM PETer [21]. The ability to customise these phantoms to simulate multiple clini-
cal scenarios also makes the designs appealing, and may lead to validation for patient 
specific anatomy as seen developing in other modalities [90]. Use of materials able to 
display similar PET and MRI properties to human tissues promotes the testing of clinical 
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protocols as would be applied to patients, and by extension greater compatibility with 
systems such as radiotherapy treatment planning or dosimetry software.
Conversely, the development, manufacture and characterisation of such phantoms can 
present a significant time commitment and an initial investment cost for sites without 
existing manufacture facilities. Even well-characterised materials such as agar introduce 
additional uncertainties to the phantoms properties as they have to be remade for each 
experiment. Across the literature in this review, description of phantom designs, the 
material properties assessed, and detail of results presented varies.
Further work is required in this area to increase the utilisation of anthropomorphic 
phantoms in PET/MRI. The Iida phantom is the only design that appears to have been 
utilised by multiple institutions [30], but have not demonstrated an adequate level of 
reproducibility. Significant investment is made into developing and characterising tis-
sue equivalent materials, yet the majority of these designs are housed in a PMMA or PU 
casing, both of which are not visible in MRI and could affect quantitative PET data when 
MRI-based attenuation correction is used.
Discussion
This review has presented an overview of the phantoms used and developed by institu-
tions for PET/MRI during the period 2011–2021. These range from simple containers 
filled with a uniform fluid to large anthropomorphic phantoms simulating human anat-
omy and physiology. Commercially available phantoms remain the dominant test objects 
in performance evaluation of PET/MRI systems, and solutions have been proposed to 
facilitate their continued use by improving MRI visibility [47, 49].
In-house design and manufacture is a more popular choice for producing anthropo-
morphic phantoms, as they are often designed with specific clinical scenarios or research 
questions in mind. Consequently, a wide range of materials, designs and manufacture 
methods are presented. The characterisation and publication of radiological materials 
for phantom construction and their comparison to human tissue properties is increasing 
which, alongside the rise in adoption of 3D printing, facilitates the more widespread use 
of tissue equivalent materials [32]. Through continued assessment of these properties 
and the uncertainties in manufacture methods, PET/MRI phantoms can move towards 
adopting standardised approaches suitable for quantitative imaging assessment and 
cross-site comparisons.
PET/MRI phantom development would benefit from an increase in options available 
from the commercial sector and professional bodies pushing for improved solutions 
for multimodal imaging systems. Of the designs presented in this review, only custom-
designed phantoms begin to address the question of creating phantoms exhibiting suit-
able radiological properties for acquiring quantitative data in both PET and MRI. This 
restricts not only the dissemination of available phantoms, but also the standardisation 
of clinical procedures and validation-related software where these phantoms have been 
used. The impact of this is that patient imaging is then not necessarily comparable across 
institutions, with particular concern if patients move across different sites during peri-
ods of monitoring reliant on quantitative PET/MRI to inform their clinical pathway.
Applying MRI-based attenuation and scatter correction to phantoms remains chal-
lenging. No commercially available phantoms exist that exhibit radiological properties 
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suitable for both PET and MRI, either as quality assurance test objects or anthropomor-
phic phantoms. PMMA remains the preferred choice for constructing phantoms, but is 
not MRI visible and is often either omitted from or incorrectly classified in MRI-derived 
attenuation maps. Polymers available for 3D printing may offer some solution to this, 
with MRI visible options available. Commercial vendors are key stakeholders in PET/
MRI phantom development, offering standardised manufacture, material properties and 
rigorous quality control to their products. As PET/MRI enters routine clinical use, cov-
ering a wider variety of applications, it can only be expected that the necessity for studies 
performed using widely available, reproducible phantoms increases.
Conclusion
Several commercially available phantoms have been demonstrated as appropriate for 
limited use in PET/MRI studies, although no vendor has yet released a phantom spe-
cifically designed and optimised for both, let alone simultaneous, PET and MRI acquisi-
tions. The development of anthropomorphic phantoms and tissue equivalent materials 
for PET/MRI has been an active field over the past decade, with an increasing focus 
toward material characterisation and reproducible manufacture. Further work is 
required to develop phantoms suitable for holistic performance evaluation of PET/MRI 
scanners and in establishing robust manufacture techniques accounting for variation in 
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